title: [Mechanical Thrombectomy - Recent Trials].
abstract: BACKGROUND
  The publications of five prospective randomized trials have made 2015 a milestone in the development of stroke therapy. Up till then, IV rtPA had been the only evidence-based recanalizing treatment for ischemic stroke.
  
  
  OBJECTIVE
  In this article we review the results of five trials: MR CLEAN, ESCAPE, EXTEND IA, SWIFT PRIME, and REVASCAT.
authors.affiliation: Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, Kirrbergerstraße, 66424, Homburg/Saar, Deutschland. umut.yilmaz@uks.eu.
authors.forename: U
authors.initials: U
authors.lastname: Yilmaz
authors.affiliation: Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, Kirrbergerstraße, 66424, Homburg/Saar, Deutschland.
authors.forename: R
authors.initials: R
authors.lastname: Mühl-Benninghaus
mesh_terms: D019317:Evidence-Based Medicine; D006801:Humans; D061185:Mechanical Thrombolysis / Q000401:mortality* / Q000706:statistics & numerical data*; D061646:Operative Time; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000175:diagnosis / Q000401:mortality* / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome
keywords: Mechanical thrombektomy; Stent retriever; Stroke